Monday, January 30, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Hearing Aids for the Masses

Jay K Joshi by Jay K Joshi
August 21, 2022
in Financial Markets
0
Hearing Aids For the Masses

In capitalism, we see consumerism as only a good thing. But sometimes, having a choice leads to only bad decisions. This is why healthcare can never fully embrace consumerism. Consumer choice makes for bad patient decisions.

We will see this play out later this year, when select hearing aids become available over the counter as soon as October 2022.

It began back in 2021, when President Joe Biden issued an executive order making hearing aids directly available. After a review by the Food and Drug Agency and a period of public commentary, the federal government formally approved the order.

As of now, it will only apply to hearing aids for those with mild to moderate hearing impairment, though that is a sizeable proportion of the hearing impaired population.

The goal is to lower the average price of hearing aids by introducing market principles of consumerism. The hope is consumer electronic companies will get into this space, which is currently dominated by a select number of hearing aid manufacturers: including ReSound, Sonova, and William Demant.

Recent history suggests otherwise. A few companies have already tried offering over the counter hearing aids, and they were unsuccessful. This includes premium audio equipment manufacturer, Bose, which received FDA clearance in 2018 for the first over the counter hearing aid. But in early 2022, the company stopped making hearing aids and instead struck a partnership with South Africa-based Lexie Hearing to sell a consumer hearing aid, “powered by Bose.”

It would seem like a curious time to create a partnership when the market has finally opened to direct sales to patients. Most predict the hearing aid market will behave in a traditionally consumer oriented way that we attribute to other consumer electronic goods, which means people will presumably buy more hearing aids than before.

Market dynamics will play out, no doubt. But the type of consumerism that will manifest may prove harmful to the patient.

Consider the smart phone: the greatest invention in past decades. It has become both a necessary tool and a status symbol. It makes for an odd combination that can be best seen in the mix of consumers who buy it.

For the minimum wage worker, these phones are quite expensive. For the well off, well, it is just another expense. But disparity matters in this context, because the draw for the smart phone is less dependent on its price, and more on the willingness to buy, more specifically, the drive for status. So people of all socioeconomic class buy expensive smart phones, regardless of how much or how little it accounts for their income.

The fervor for status negates any decision making based on the economic utility gleaned through the phone’s value. People would rather purchase a phone that gives them status instead of a phone based on the utility it provides.

We must heed this important lesson when we promote healthcare consumerism to address economic disparity in healthcare. For patients who purchase a phone, the appeal for status creates price inelasticity, which means the market is not defined by pricing pressure.

Hearing aids may very well follow this model. The first indicator that hearing aids will be a status oriented, price inelastic market will be the number of successful distribution channels that emerge. Bose’s partnership with Lexie Hearing suggests we may have fewer distribution channels than anticipated, which mirrors the smart phone market. It suggests price will have little effect on hearing aid sales.

Distribution channels are often overlooked because they do not have an easily observable influence on consumer markets like status, but they distinguish healthcare markets.

We think the push for consumerism will flood the market with many distribution channels, but only a few will win out. This is because patients are not consumers. And for patients, price is not a driver of purchasing behavior.

Patients will not purchase hearing aids at Best Buy like they would a computer mouse. They will purchase them through select distribution channels that are recommended by a trusted medical provider or a close acquaintance. The few distribution channels that earn a reputation as the trusted source for quality hearing aids will win out. The rest will close shop soon enough.

Status and trust are the dynamics that influence healthcare consumerism. It is no different from explaining why patients go to more expensive hospitals affiliated with large academic medical centers instead of local community hospitals.

When hearing aids become available, we will see similar patterns of behavior. Many new entrants will come into the market, hoping to capture some market share through lower prices and discounts. They will lose. The players that will win are the ones who sell premium hearing aids and invest heavily in building trust and status.

Once hearing aids become a status symbol, we will see the worst of healthcare consumerism. Soon we will see the moral hazards. And we suspect we will see a rise in diagnoses for mild to moderate hearing impairment – not because hearing aids are more accessible or affordable, but because they are expensive and trendy.

This is healthcare consumerism. We think we will see the best of market dynamics. Rather, we will see the worst of patient behavior.

Remember, it is impossible to align the many individual patient incentives through any one policy. Patients do not respond to the intended effects of a policy, they respond to the moral hazards within it.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Letter to the Alabama Board of Medical Examiners

    Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0
  • Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • Why Our Prescribing were for Patients’ Best Interests

    0 shares
    Share 0 Tweet 0
  • My Respect for the Law

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do